Thus, nucleotide metabolism is not only a metabolic hallmark of CRC but acts as a central focal point that coordinates tumor-stromal-immune signaling (via MIF/PLA2/BAFF/TFRC) and spatially co-localizes with oncogenic pathways. This evidence concerns the gene PLA2G2A and neoplasm.